Catherine J. Mackey - Apr 5, 2022 Form 4 Insider Report for IDEAYA Biosciences, Inc. (IDYA)

Role
Director
Signature
/s/ Jason Throne, as Attorney-in-Fact for Catherine J. Mackey
Stock symbol
IDYA
Transactions as of
Apr 5, 2022
Transactions value $
$0
Form type
4
Date filed
4/6/2022, 04:23 PM
Previous filing
Dec 16, 2021
Next filing
Aug 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDYA Stock Option (Right to Buy) Award $0 +22K $0.00 22K Apr 5, 2022 Common Stock 22K $11.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the shares subject to the option vest on each monthly anniversary measured from April 5, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date.